Extension in AS: Sustainability of Benefits, Safety and Tolerability
Completed · Phase 3 · Has a placebo group
Conditions studied: Spondylitis, Ankylosing
In brief
This 3-year extension study aims at making available the treatment with secukinumab in prefilled syringes (PFS) to patients with ankylosing spondylitis who took part in phase III study CAIN457F2305, defined as "core study", as well as to generate additional data on the sustainability of clinical benefits, safety and tolerability during long-term administration of secukinumab.
Key facts
- Study ID
- NCT01863732
- Run by
- Novartis Pharmaceuticals
- People needed
- 274
- Starts
- 2013-11-06
- Expected to finish
- 2018-03-16
- Last updated by the study team
- 2019-07-30
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Novartis Investigative Site — Duncansville, Pennsylvania, United States
- Novartis Investigative Site — Jackson, Tennessee, United States
- Novartis Investigative Site — Kingsport, Tennessee, United States
- Novartis Investigative Site — Spokane, Washington, United States
- Novartis Investigative Site — Brussels, Belgium
- Novartis Investigative Site — Genk, Belgium
- Novartis Investigative Site — Ghent, Belgium
- Novartis Investigative Site — Leuven, Belgium
- Novartis Investigative Site — Burgas, Bulgaria
- Novartis Investigative Site — Plovdiv, Bulgaria
- Novartis Investigative Site — Plovdiv, Bulgaria
- Novartis Investigative Site — Sofia, Bulgaria
- Novartis Investigative Site — Sofia, Bulgaria
- Novartis Investigative Site — Winnipeg, Manitoba, Canada
- Novartis Investigative Site — St. John's, Newfoundland and Labrador, Canada
- Novartis Investigative Site — Limoges, Haute Vienne, France
- Novartis Investigative Site — Bordeaux, France
- Novartis Investigative Site — Paris, France
- Novartis Investigative Site — Berlin, Germany
- Novartis Investigative Site — Cologne, Germany
- Novartis Investigative Site — Erlangen, Germany
- Novartis Investigative Site — Hamburg, Germany
- Novartis Investigative Site — Herne, Germany
- Novartis Investigative Site — Magdeburg, Germany
- Novartis Investigative Site — Portland, Oregon, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.